RQx Pharmaceuticals Inc.

Spero Therapeutics LLC , launched in 2013 with seed funding from Atlas Venture with a focus on developing novel antibiotics for gram-negative infections, has signed its first partner. The Cambridge, M

Spero Therapeutics LLC , launched in 2013 with seed funding from Atlas Venture with a focus on developing novel antibiotics for gram-negative infections, has signed its first partner. The Cambridge,

Financings In the first quarter of 2013, start-up companies generated a total of $398.7 million across all industries, which was a 59% drop from the previous quarter’s $670.3 million. ( See Exhibit 1.

Financings – Biopharma financing had a strong start in 2013; the first quarter – with 86 biopharma financings bringing in $4.6 billion – already exceeding Q4 2012, last year’s strongest quarter, which